European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Next PostHMOs offer protection from tooth decay as formula ingredient You Might Also Like Global Prebiotic Association Welcomes Membership May 9, 2018 Prebiotics may help fight rotavirus: Study September 23, 2017 Resistant Starch 4 greenlighted as US FDA expands dietary fiber classification April 1, 2019